(Q72769499)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8306501%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

title

Anti-idiotypic activity against anti-myeloperoxidase antibodies in pooled human immunoglobulin (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8306501%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

author name string

A A Pall

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8306501%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

M Varagunam

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8306501%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

D Adu

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8306501%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

N Smith

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8306501%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

N T Richards

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8306501%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

C M Taylor

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8306501%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

J Michael

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8306501%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

publication date

1 February 1994

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8306501%20AND%20SRC:MED&resulttype=core&format=json

Clinical and Experimental Immunology

29 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8306501%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

volume

95

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8306501%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8306501%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

page(s)

257-262

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8306501%20AND%20SRC:MED&resulttype=core&format=json

High-dose intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy: a double-blind, placebo-controlled, crossover study

29 October 2019

cites work

1 reference

12 December 2020

Endothelium myeloperoxidase-antimyeloperoxidase interaction in vasculitis

1 reference

12 December 2020

Normal immunoglobulin G (IgG) for therapeutic use (intravenous Ig) contain antiidiotypic specificities against an immunodominant, disease-associated, cross-reactive idiotype of human anti-thyroglobulin autoantibodies

1 reference

12 December 2020

Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro

1 reference

12 December 2020

Idiotypic interactions between normal human polyspecific IgG and natural IgM antibodies

1 reference

12 December 2020

Titration of antibodies against neutrophil cytoplasmic antigens is useful in monitoring disease activity in systemic vasculitides

1 reference

12 December 2020

Anti-idiotypes against anti-neutrophil cytoplasmic antigen autoantibodies in normal human polyspecific IgG for therapeutic use and in the remission sera of patients with systemic vasculitis

1 reference

12 December 2020

Treatment of systemic vasculitis with pooled intravenous immunoglobulin

1 reference

12 December 2020

A Single Intravenous Infusion of Gamma Globulin as Compared with Four Infusions in the Treatment of Acute Kawasaki Syndrome

1 reference

12 December 2020

Human immunoglobulin preparation for intravenous use induces elevation of cellular cyclic adenosine 3':5'-monophosphate levels, resulting in suppression of tumour necrosis factor alpha and interleukin-1 production

1 reference

12 December 2020

Normal serum immunoglobulins participate in the selection of peripheral B-cell repertoires

1 reference

12 December 2020

Mechanisms of action of intravenous immunoglobulin therapy and potential use in autoimmune connective tissue diseases

1 reference

12 December 2020

High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood

1 reference

12 December 2020

Transient reversal of thrombocytopenia in idiopathic thrombocytopenic purpura by high-dose intravenous gamma globulin

1 reference

12 December 2020

Intravenous gammaglobulin treatment of chronic idiopathic thrombocytopenic purpura

1 reference

12 December 2020

Modulation of mononuclear phagocyte function by intravenous gamma-globulin

1 reference

12 December 2020

Anti-idiotypic suppression of autoantibodies to factor VIII (antihaemophilic factor) by high-dose intravenous gammaglobulin

1 reference

12 December 2020

Intravenous immunoglobulin versus oral corticosteroids in acute immune thrombocytopenic purpura in childhood

1 reference

12 December 2020

Cellular mechanisms in the in vitro inhibition of pokeweed mitogen-induced B cell differentiation by immunoglobulin for intravenous use

1 reference

12 December 2020

Use of intravenous gamma globulin for the treatment of autoimmune neutropenia of childhood and autoimmune hemolytic anemia

1 reference

12 December 2020

Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis

1 reference

12 December 2020

Regulation of autoantibodies in inflammatory demyelinating polyneuropathy: spontaneous and therapeutic

1 reference

12 December 2020

Anti-idiotypes against autoantibodies in normal immunoglobulins: evidence for network regulation of human autoimmune responses

1 reference

12 December 2020

Modulation of in vitro synthesis of immunoglobulin and the induction of suppressor activity by therapy with intravenous immune globulin

1 reference

12 December 2020

Inhibition of autoantibody binding to platelet glycoprotein IIb/IIIa by anti-idiotypic antibodies in intravenous gammaglobulin.

1 reference

12 December 2020

Mechanism of therapeutic effect of high-dose intravenous immunoglobulin. Attenuation of acute, complement-dependent immune damage in a guinea pig model

1 reference

12 December 2020

Stimulation of B and T cells by in vivo high dose immunoglobulin administration in normal mice

1 reference

12 December 2020

Intravenous immunoglobulins (IVIg) in the treatment of autoimmune diseases

1 reference

12 December 2020

Anti-myeloperoxidase antibodies stimulate neutrophils to damage human endothelial cells

1 reference

12 December 2020

Origin of anti-idiotypic activity against anti-factor VIII autoantibodies in pools of normal human immunoglobulin G (IVIg)

1 reference

12 December 2020

Antineutrophil cytoplasmic antibody (cANCA and pANCA) titers in relation to disease activity in patients with necrotizing vasculitis: a longitudinal study

1 reference

12 December 2020

Autoantibodies developing to myeloperoxidase and proteinase 3 in systemic vasculitis stimulate neutrophil cytotoxicity toward cultured endothelial cells

1 reference

12 December 2020

Anti-myeloperoxidase antibodies in systemic vasculitis

1 reference

12 December 2020

10.1111/J.1365-2249.1994.TB06520.X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8306501%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

1 reference